Member Exclusive Interview

Advancing the discovery of CNS active drugs: an interview with Li Yu and Holger Fischer

At AAPS 2019 PharmSci 360 (3–6 November 2019; TX, USA), we spoke with Li Yu and Holger Fischer (both at Roche; NY, USA and Basel, Switzerland, respectively) to learn more about their work on entrectinib, a novel drug with the ability to cross the blood–brain barrier and treat brain tumors.

Go to the profile of RxNet
Dec 09, 2019

Please sign in or register for FREE

No comments yet.